Latest News & Features
Americas
New Jersey judge denies motion to stay antitrust action regarding blockbuster cancer drug | Defendants had argued litigation would be unnecessary and costly. 25 April 2023
Big Pharma
Canadian firm alleges infringement of patent directed to cosmetic and pharmaceutical formulations | Pharma giant declined a licensing agreement. 20 April 2023
Big Pharma
Court affirms decision that two Otezla patents are not invalid | Apremilast generics set for 2028 release. 20 April 2023
Americas
Petition to review invalidation of Gilenya patent denied | Novartis challenged decision resulting from a change in judicial panel. 18 April 2023
Americas
It may not be straightforward but it is possible to obtain protection for valuable combination patents in Brazil, say Lívia Figueiredo and Priscila Kashiwabara of Kasznar Leonardos Intellectual Property. 13 April 2023
Americas
Precedential decision upholds lower court’s earlier finding | Patent at heart of the dispute covers treatment patch for Parkinson’s. 13 April 2023
Americas
Biotech fails to convince Federal Circuit to overturn PTAB finding | Invalidation of patent related to “Non-liposomal systems for nucleic acid delivery”. 12 April 2023
Americas
Feud concerned the ownership of six immunotherapy patents |
Cancer centre claimed that it was unfairly deprived of royalties. 11 April 2023
Big Pharma
Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him |
Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017. 11 April 2023
Big Pharma
Feud involved a blockbuster cancer drug belonging to a family of PARP inhibitors | GSK unit failed to persuade the court of the merits of its ‘certain uses’ argument. 6 April 2023